Pursuant to Regulation 33 and Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 20th January, 2025 has inter-alia adopted and approved 1)The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2024. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2024.
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held On 20Th January 2025.
View original source (BSE India)Rekvina Laboratories Ltd. on 6ix
Earlier from Rekvina Laboratories
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Rekvina Laboratories Ltd. Press Release Jan 13 2025
- Board Meeting Intimation for Board Meeting To Be Held On 20Th January, 2025.
- Reply With Respect To Reason For Delay Submission Of Information Regarding Resignation Of Chief Financial Officer To The Exchange Within 24 Hours From The Effective Date Of Resignation.
- Rekvina Laboratories Ltd. Press Release Jan 08 2025
Later from Rekvina Laboratories
- Quarter And Nine Months Ended On 31St December 2024.
- Rekvina Laboratories Ltd. Press Release Jan 20 2025
- Integrated Filing (Financial)
- Rekvina Laboratories Ltd. Press Release Jan 30 2025
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Follow Rekvina Laboratories into a list and get an email when it puts out news.
Follow Rekvina Laboratories